21-hydroxy-6,19-oxidoprogesterone: A novel synthetic steroid with specific antiglucocorticoid properties in the rat

In the rat, the conformationally highly befit steroid 21-hydroxy-6,19- oxidoprogesterone efficiently displaces [3H]corticostetone from thymus- glucocorticoid receptors and blocks type II receptors in kidney cytosols but competes with neither [3H]aldosterona for kidney-mineralocorticoid receptors nor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vicent, Guillermo Pablo, Veleiro, Adriana Silvia, Burton, Gerardo
Publicado: 1997
Materias:
rat
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_0026895X_v52_n4_p749_Vicent
http://hdl.handle.net/20.500.12110/paper_0026895X_v52_n4_p749_Vicent
Aporte de:
id paper:paper_0026895X_v52_n4_p749_Vicent
record_format dspace
spelling paper:paper_0026895X_v52_n4_p749_Vicent2023-06-08T14:53:55Z 21-hydroxy-6,19-oxidoprogesterone: A novel synthetic steroid with specific antiglucocorticoid properties in the rat Vicent, Guillermo Pablo Veleiro, Adriana Silvia Burton, Gerardo 11beta,17beta dihydroxy 6 methyl 17alpha (1 propynyl)androsta 1,4,6 trien 3 one 15beta,16beta methylenemexrenone 21 hydroxy 6,19 oxidoprogesterone aldosterone corticosterone dexamethasone glucocorticoid antagonist glucocorticoid receptor mineralocorticoid receptor progesterone steroid tyrosine aminotransferase unclassified drug animal tissue article controlled study cytosol dose response drug conformation drug receptor binding enzyme induction kidney cell male nonhuman priority journal rat sodium retention In the rat, the conformationally highly befit steroid 21-hydroxy-6,19- oxidoprogesterone efficiently displaces [3H]corticostetone from thymus- glucocorticoid receptors and blocks type II receptors in kidney cytosols but competes with neither [3H]aldosterona for kidney-mineralocorticoid receptors nor [3H]progesterone for uterus-progesterone receptors. It evokes Na+ retention only at very high doses (~100 μg/100 g of rat weight) and is unable to induce tyrosine aminotransferase or to increase glycogen deposits in rat liver. When coincubated with corticostarone or dexamethasone, 2.5 μM 21OH-6OP inhibits 80% of tyrosine, aminotransferase induction. It may therefore be used experimentally as an antiglucocorticoid virtually lacking mineralocorticoid or glucocorticoid properties as well as affinity for mineralocorticoid or progesterone receptors. Fil:Vicent, G.P. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Veleiro, A.S. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Burton, G. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 1997 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_0026895X_v52_n4_p749_Vicent http://hdl.handle.net/20.500.12110/paper_0026895X_v52_n4_p749_Vicent
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic 11beta,17beta dihydroxy 6 methyl 17alpha (1 propynyl)androsta 1,4,6 trien 3 one
15beta,16beta methylenemexrenone
21 hydroxy 6,19 oxidoprogesterone
aldosterone
corticosterone
dexamethasone
glucocorticoid antagonist
glucocorticoid receptor
mineralocorticoid receptor
progesterone
steroid
tyrosine aminotransferase
unclassified drug
animal tissue
article
controlled study
cytosol
dose response
drug conformation
drug receptor binding
enzyme induction
kidney cell
male
nonhuman
priority journal
rat
sodium retention
spellingShingle 11beta,17beta dihydroxy 6 methyl 17alpha (1 propynyl)androsta 1,4,6 trien 3 one
15beta,16beta methylenemexrenone
21 hydroxy 6,19 oxidoprogesterone
aldosterone
corticosterone
dexamethasone
glucocorticoid antagonist
glucocorticoid receptor
mineralocorticoid receptor
progesterone
steroid
tyrosine aminotransferase
unclassified drug
animal tissue
article
controlled study
cytosol
dose response
drug conformation
drug receptor binding
enzyme induction
kidney cell
male
nonhuman
priority journal
rat
sodium retention
Vicent, Guillermo Pablo
Veleiro, Adriana Silvia
Burton, Gerardo
21-hydroxy-6,19-oxidoprogesterone: A novel synthetic steroid with specific antiglucocorticoid properties in the rat
topic_facet 11beta,17beta dihydroxy 6 methyl 17alpha (1 propynyl)androsta 1,4,6 trien 3 one
15beta,16beta methylenemexrenone
21 hydroxy 6,19 oxidoprogesterone
aldosterone
corticosterone
dexamethasone
glucocorticoid antagonist
glucocorticoid receptor
mineralocorticoid receptor
progesterone
steroid
tyrosine aminotransferase
unclassified drug
animal tissue
article
controlled study
cytosol
dose response
drug conformation
drug receptor binding
enzyme induction
kidney cell
male
nonhuman
priority journal
rat
sodium retention
description In the rat, the conformationally highly befit steroid 21-hydroxy-6,19- oxidoprogesterone efficiently displaces [3H]corticostetone from thymus- glucocorticoid receptors and blocks type II receptors in kidney cytosols but competes with neither [3H]aldosterona for kidney-mineralocorticoid receptors nor [3H]progesterone for uterus-progesterone receptors. It evokes Na+ retention only at very high doses (~100 μg/100 g of rat weight) and is unable to induce tyrosine aminotransferase or to increase glycogen deposits in rat liver. When coincubated with corticostarone or dexamethasone, 2.5 μM 21OH-6OP inhibits 80% of tyrosine, aminotransferase induction. It may therefore be used experimentally as an antiglucocorticoid virtually lacking mineralocorticoid or glucocorticoid properties as well as affinity for mineralocorticoid or progesterone receptors.
author Vicent, Guillermo Pablo
Veleiro, Adriana Silvia
Burton, Gerardo
author_facet Vicent, Guillermo Pablo
Veleiro, Adriana Silvia
Burton, Gerardo
author_sort Vicent, Guillermo Pablo
title 21-hydroxy-6,19-oxidoprogesterone: A novel synthetic steroid with specific antiglucocorticoid properties in the rat
title_short 21-hydroxy-6,19-oxidoprogesterone: A novel synthetic steroid with specific antiglucocorticoid properties in the rat
title_full 21-hydroxy-6,19-oxidoprogesterone: A novel synthetic steroid with specific antiglucocorticoid properties in the rat
title_fullStr 21-hydroxy-6,19-oxidoprogesterone: A novel synthetic steroid with specific antiglucocorticoid properties in the rat
title_full_unstemmed 21-hydroxy-6,19-oxidoprogesterone: A novel synthetic steroid with specific antiglucocorticoid properties in the rat
title_sort 21-hydroxy-6,19-oxidoprogesterone: a novel synthetic steroid with specific antiglucocorticoid properties in the rat
publishDate 1997
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_0026895X_v52_n4_p749_Vicent
http://hdl.handle.net/20.500.12110/paper_0026895X_v52_n4_p749_Vicent
work_keys_str_mv AT vicentguillermopablo 21hydroxy619oxidoprogesteroneanovelsyntheticsteroidwithspecificantiglucocorticoidpropertiesintherat
AT veleiroadrianasilvia 21hydroxy619oxidoprogesteroneanovelsyntheticsteroidwithspecificantiglucocorticoidpropertiesintherat
AT burtongerardo 21hydroxy619oxidoprogesteroneanovelsyntheticsteroidwithspecificantiglucocorticoidpropertiesintherat
_version_ 1768543789285113856